4-(3-Methylbutoxy)aniline hydrochloride (1:1)

Modify Date: 2025-08-25 13:33:02

4-(3-Methylbutoxy)aniline hydrochloride (1:1) Structure
4-(3-Methylbutoxy)aniline hydrochloride (1:1) structure
Common Name 4-(3-Methylbutoxy)aniline hydrochloride (1:1)
CAS Number 10141-51-2 Molecular Weight 215.72
Density N/A Boiling Point 322.1ºC at 760 mmHg
Molecular Formula C11H18ClNO Melting Point 154-159ºC
MSDS Chinese USA Flash Point 148.6ºC
Symbol GHS07
GHS07
Signal Word Warning

 Use of 4-(3-Methylbutoxy)aniline hydrochloride (1:1)


CP-24879 (hydrochloride) is a potent, selective and combined delta5D/delta6D inhibitor. CP-24879 (hydrochloride) can significantly reduce intracellular lipid accumulation and inflammatory injury in hepatocytes. CP-24879 (hydrochloride) exhibits superior antisteatotic and anti-inflammatory actions in fat-1 and ω-3-treated hepatocytes, and can be used for non-alcoholic steatohepatitis research[1][2].

 Names

Name 4-(3-methylbutoxy)aniline,hydrochloride
Synonym More Synonyms

  Biological Activity

Description CP-24879 (hydrochloride) is a potent, selective and combined delta5D/delta6D inhibitor. CP-24879 (hydrochloride) can significantly reduce intracellular lipid accumulation and inflammatory injury in hepatocytes. CP-24879 (hydrochloride) exhibits superior antisteatotic and anti-inflammatory actions in fat-1 and ω-3-treated hepatocytes, and can be used for non-alcoholic steatohepatitis research[1][2].
Related Catalog
Target

IC50: 0.015 μM (delta6D in ABMC-7 cells), 0.56 μM (delta6D in Liver microsomes), 0.67 μM (delta5D in ABMC-7 cells), 3.4 μM (delta5D in ABMC-7 cells)[1]

In Vitro CP-24879 (hydrochloride) (0-10 μM, 4 days) inhibits Δ6 + Δ5 desaturase activities in a concentration-dependent manner, with a concentration-dependent depletion of AA and decrease in LTC4 production[1]. CP-24879 (hydrochloride) (0-10 μM, 16 h) shows the inhibitory responses on oleic acid-induced triglyceride accumulation in hepatocytes[2]. CP-24879 (hydrochloride) (0-10 μM, 16 h) blocks LPS-induced expression of inflammatory cytokines in a concentration-dependent manner[2]. CP-24879 (hydrochloride) (0-2 μM, 4 h) inhibits desaturase activity and ameliorates ferroptosis[3]. Cell Viability Assay Cell Line: Mouse mastocytoma ABMC-7 cells[1] Concentration: 0, 100 nM, 300 nM, 1 μM, 3 μM, and 10 μM Incubation Time: 4 days Result: Inhibited Δ6 + Δ5 desaturase activities in a concentration-dependent manner, with a concentration-dependent depletion of AA and decrease in LTC4 (Leukotriene C4) production, and did not inhibit either 5-lipoxygenase or LTC4 synthase activity.
In Vivo CP-24879 (hydrochloride) (3 mg/kg, IP, three times a day, for 6 or 4 days) inhibits Δ6 + Δ5 desaturase activities in vivo, causing depletion of AA in the livers of chow-fed mice and preventing repletion of AA in the livers of EFAD mice[1]. CP-24879 (hydrochloride) (33 mg/kg, IV, once) is cleared quite rapidly and has a relatively short half-life[1]. Animal Model: Chow-fed and EFAD Balb/C mice (N = 5/group) [1] Dosage: 3 mg/kg Administration: IP, three times a day, for 6 or 4 days Result: Inhibited approximately 80% combined Δ6 + Δ5 desaturase activities, causing depletion of AA in the livers of chow-fed mice and preventing repletion of AA in the livers of EFAD mice, and increased OA and LA, with a higher ratio of LA/AA in the livers of mice injected with CP-24879 versus saline (4.70 vs 2.00, Chow-fed mice; 2.46 vs 1.40, EFAD mice; respectively). Animal Model: Swiss-Webster mice (male, 25 g) [1] Dosage: 33 mg/kg Administration: IV in the tail vein, once (Pharmacokinetic Analysis) Result: Was readily distributed to the peripheral tissues, with the volume of distribution (V) of 1.9 mL/g, was cleared quite rapidly (CL = 0.56 mL/min) and had a relatively short half-life (T1/2 = 59 min).
References

[1]. Obukowicz MG, et al. Identification and characterization of a novel delta6/delta5 fatty acid desaturase inhibitor as a potential anti-inflammatory agent. Biochem Pharmacol. 1998 Apr 1;55(7):1045-58.

[2]. [2]López-Vicario C, et al. Molecular interplay between Δ5/Δ6 desaturases and long-chain fatty acids in the pathogenesis of non-alcoholic steatohepatitis. Gut. 2014 Feb;63(2):344-55.

[3]. [3]Lee JY, Nam M, Son HY, et al. Polyunsaturated fatty acid biosynthesis pathway determines ferroptosis sensitivity in gastric cancer. Proc Natl Acad Sci U S A. 2020;117(51):32433-32442.

 Chemical & Physical Properties

Boiling Point 322.1ºC at 760 mmHg
Melting Point 154-159ºC
Molecular Formula C11H18ClNO
Molecular Weight 215.72
Flash Point 148.6ºC
Exact Mass 215.107697
PSA 35.25000
LogP 4.07690
Vapour Pressure 0.000208mmHg at 25°C

 Safety Information

Symbol GHS07
GHS07
Signal Word Warning
Hazard Statements H315-H319-H335
Precautionary Statements P305 + P351 + P338
Personal Protective Equipment dust mask type N95 (US);Eyeshields;Gloves
Hazard Codes Xi
Risk Phrases 36/37/38
Safety Phrases 26-36
RIDADR NONH for all modes of transport

 Synonyms

4-(3-Methylbutoxy)aniline hydrochloride (1:1)
Benzenamine, 4-(3-methylbutoxy)-, hydrochloride (1:1)
4-Isopentyloxy-anilin,Hydrochlorid
4-isopentyloxy-aniline,hydrochloride
p-Isopentoxyaniline
The content on this webpage is sourced from various professional data sources. If you have any questions or concerns regarding the content, please feel free to contact service1@chemsrc.com.
Top Suppliers:I want be here



Get all suppliers and price by the below link:

4-(3-Methylbutoxy)aniline hydrochloride (1:1) suppliers

4-(3-Methylbutoxy)aniline hydrochloride (1:1) price

Related Compounds: More...
3-Methyl-4-(3-methylbutoxy)aniline hydrochloride (1:1)
1185302-34-4
4-Methyl-2-(3-methylbutoxy)aniline hydrochloride (1:1)
1185295-20-8
4-(3-Methylphenoxy)aniline hydrochloride (1:1)
56705-84-1
4-(3-Isopropylphenoxy)aniline hydrochloride (1:1)
1185297-59-9
4-(3,4-Dimethylphenoxy)aniline hydrochloride (1:1)
1185297-66-8
4-(3-Fluorophenoxy)-3-(trifluoromethyl)aniline hydrochloride (1:1)
1185304-41-9
3-Chloro-4-(3-fluorophenoxy)aniline hydrochloride (1:1)
1185297-43-1
4-[4-[3-CHLORO-5-(TRIFLUOROMETHYL)-2-PYRIDINYL]PIPERAZINO]BENZENAMINIUM CHLORIDE
321848-37-7
3-Fluoro-4-(3-methylbutoxy)aniline
946785-49-5
7-Bromo-2-methoxy-8-methylquinoline
944407-49-2
2-(Azetidin-3-yloxy)-3-methylpyridine
1340574-36-8
N-methyl-N-(2-methylsulfanylpyrimidin-4-yl)-1H-indazol-4-amine
945396-98-5
1,4-Diaza-bicyclo[3.2.2]nonane-4-carboxylic acid 4-(4,4,5,5-tetramethyl-[1,3,2]dioxaborolan-2-yl)-phenyl ester
446022-34-0
5-methoxy-6-methyl-1H-indole-2-carboxylic acid
3139-08-0
(5-Cyclopropyl-1,2-oxazol-4-yl)methanamine
1428234-43-8
1-Piperidinecarboxamide, N-[2-[[5-amino-1-[[4-(4-pyridinyl)-1-piperazinyl]carbonyl]pentyl]amino]-1-[(3,5-dibromo-4-hydroxyphenyl)methyl]-2-oxoethyl]-4-(1,4-dihydro-2,4-dioxo-3(2H)-quinazolinyl)-, [R-(R*,S*)]-
204697-64-3
[(1S,4R,6S,7Z,14S,18R)-4-[(4-cyanophenyl)sulfonylcarbamoyl]-14-[(2-methylpropan-2-yl)oxycarbonylamino]-2,15-dioxo-3,16-diazatricyclo[14.3.0.04,6]nonadec-7-en-18-yl] 1,3-dihydroisoindole-2-carboxylate
1439898-11-9
4-(2,3-Dimethylphenyl)-5-thioxo-1,2,4-triazolidin-3-one
110062-46-9
[(4'-Bromo-3',6-dimethyl-2-biphenylyl)methoxy](tert-butyl)dimethylsilane
1307795-60-3